Synthesis of 4-methoxy-1,3-benzenediolylhydrazones and evaluation of their anti-platelet aggregation activity

Authors

  • Chaoqing Wang School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, China. |Tianjin Key Laboratory of Organic Solar Cells and Photochemical Conversion, School of Chemistry and Chemical Engineering Tianjin University of Technology, Tianjin 300384, China.
  • Qingsong Deng School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, China.
  • Xiujie Liu School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, China. |Tianjin Key Laboratory of Organic Solar Cells and Photochemical Conversion, School of Chemistry and Chemical Engineering Tianjin University of Technology, Tianjin 300384, China.
  • Yan Wang School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, China.
Abstract:

In our present investigation, a series of novel 4-methoxy-1,3-benzenediolyl-hydrazones were designed and synthesized, and their ability to inhibit platelet aggregation was evaluated by adenosine diphosphate (ADP) and arachidonic acid (AA). The structures of the synthesized compounds were confirmed by spectral data. Results demonstrated that the activities of all compounds excelled the positive drug Picotamide (25.1 % inhibition rate) and seven compounds (PNN01, PNN03, PNN05, PNN07, PNN09, PNN12, PNN14) have efficiently inhibited platelet aggregation even higher than Clopidogrel (37.6 % inhibition rate) induced by AA. Among them, PNN07 (39.8 % inhibition rate) was considered as the most potent analogue. Evaluation of cytotoxic activity of the compounds against L929 cell line revealed that none of the compounds have significant cytotoxicity. Thus, diolylhydrazones derives are potential to be antiplatelet aggregation inhibitors and maybe working in AA-induced selectively.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

synthesis of thioether derivatives and evaluation of their anti-platelet-aggregation activity

full text

Evaluation of anti-platelet aggregation effect of some Allium species

Epidemiologic studies show that the cardiovascular diseases are associated with multiple factors such as raised serum total cholesterol, increased LDL, increased platelet aggregation, hypertension and smoking. In-vitro studies have confirmed the ability of some plants of Allium species to reduce these parameters. Therefore, we evaluated anti-platelet aggregation effect of some Allium species (A...

full text

Evaluation of anti-platelet aggregation effect of some Allium species

Epidemiologic studies show that the cardiovascular diseases are associated with multiple factors such as raised serum total cholesterol, increased LDL, increased platelet aggregation, hypertension and smoking. In-vitro studies have confirmed the ability of some plants of Allium species to reduce these parameters. Therefore, we evaluated anti-platelet aggregation effect of some Allium species (A...

full text

synthesis and evaluation of anti platelet aggregation activity of new thiohydantoin derivatives

full text

comparison of catalytic activity of heteropoly compounds in the synthesis of bis(indolyl)alkanes.

heteropoly acids (hpa) and their salts have advantages as catalysts which make them both economically and environmentally attractive, strong br?nsted acidity, exhibiting fast reversible multi-electron redox transformations under rather mild conditions, very high solubility in polar solvents, fairly high thermal stability in the solid states, and efficient oxidizing ability, so that they are imp...

15 صفحه اول

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 18  issue 4

pages  1803- 1815

publication date 2019-12-01

{@ msg @}

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023